BridgeBio Pharma
BBIO
BBIO
116 hedge funds and large institutions have $3.82B invested in BridgeBio Pharma in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 43 increasing their positions, 23 reducing their positions, and 10 closing their positions.
Holders
116
Holders Change
+21
Holders Change %
+22.11%
% of All Funds
2.38%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.16%
New
32
Increased
43
Reduced
23
Closed
10
Calls
$25.4M
Puts
$743K
Net Calls
+$24.7M
Net Calls Change
+$16.6M
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$189M |
2 |
2
State Street
Boston,
Massachusetts
|
$104M |
3 |
3
Citigroup
New York
|
$26.4M |
4 |
CS
4
Credit Suisse
Zurich,
Switzerland
|
$17.8M |
5 |
5
BlackRock
New York
|
$181M |